Menopause: What Your Body Is Going Through and What You Can Actually Do About It

Key Takeaways

• Menopause is defined as 12 consecutive months without a menstrual period; the average age in the U.S. is 51 to 52.
• Symptoms typically persist seven or more years and affect sleep, mood, weight, bone density, cardiovascular health, cognition, and sexual function.
• Cardiovascular disease risk rises sharply after menopause as estrogen's protective effects decline, making this transition a key window for prevention (El Khoudary et al., 2020, Circulation; American Heart Association Scientific Statement).
• The FDA removed class-wide boxed warnings on menopausal hormone therapy in November 2025, reflecting updated evidence on safety; VIMC prescribes customized bioidentical hormone therapy through credible compounding pharmacies and integrates testosterone when clinically indicated.
• VIMC actively prescribes hormone therapy to women in their 60s and 70s when no overt contraindications exist; age is a clinical guide, not a categorical limit.

If you have ever found yourself lying awake at 3 a.m. drenched in sweat, wondering what is happening to your body, you are in good company. Menopause affects every woman at some point, yet most of us were never given a real roadmap. The changes touch sleep, mood, weight, memory, libido, and more.

Menopause does not have to mean years of suffering. With the right information and support, this transition can become one of the most empowering chapters of your life. At Venus Integrative Medical Center (VIMC) in Mesa, Arizona, the team sees women every day who have been told their symptoms are just part of getting older.

What is Menopause, Really?

Menopause is clinically defined as 12 consecutive months without a menstrual period in a woman over the age of 40, not caused by pregnancy or another medical condition. In the United States, natural menopause occurs at an average age of 51 to 52. The full experience spans three distinct stages:

• Perimenopause: the multi-year hormonal transition before menopause, during which cycles become irregular and most symptoms begin.
• Menopause: the single clinical milestone that marks the end of the reproductive years.
• Postmenopause: every year of life that follows.

Most women are surprised to learn that estrogen is not the first hormone to fall. Progesterone declines first as the ovaries begin skipping ovulation more frequently, often years before estrogen shifts noticeably. Without progesterone’s calming effects on GABA receptors in the brain, women may begin experiencing anxiety, worsening PMS, and middle-of-the-night waking while standard lab tests still look completely normal. This is one of the most common reasons perimenopause goes unrecognized for so long.

When Does Menopause Happen, and How Long Does it Last?

The natural range for menopause spans roughly ages 45 to 58, with the average at 51 to 52. Perimenopause can begin as early as the mid-to-late 30s, though most women notice it more prominently in their 40s. Approximately 1% of women experience primary ovarian insufficiency, meaning menopause occurs before age 40, which warrants thorough evaluation.

Research published in JAMA Internal Medicine analyzing data from the Study of Women’s Health Across the Nation (SWAN) found that vasomotor symptoms such as hot flashes and night sweats persist for a median of 7.4 years across the menopausal transition, and for some women longer. Women who began experiencing symptoms earliest in perimenopause tended to have the longest symptom duration. Effective, individualized treatment can substantially reduce that burden throughout the entire window.

The Symptoms of Menopause (Far Beyond Hot Flashes)

One of the reasons menopause is so frequently underdiagnosed is the sheer variety of symptoms it can produce:

• Hot flashes and night sweats (vasomotor symptoms), among the most universal and most disruptive features of the transition.
• Sleep disturbances, ranging from difficulty falling asleep to 2 or 3 a.m. waking, often driven by both falling progesterone and night sweats.
• Genitourinary syndrome of menopause (GSM): vaginal dryness, urinary urgency, painful intercourse, and pelvic discomfort.
• Decreased libido, linked in part to declining testosterone, not estrogen alone.
• Unexplained weight gain, particularly around the midsection.
• Joint pain and muscle stiffness, due to the loss of estrogen’s anti-inflammatory effects.
• Cognitive and mood changes: brain fog, memory lapses, anxiety, irritability, and low mood.

How Menopause Affects Your Brain, Mood, and Sleep

Cognitive and emotional symptoms are often the most disruptive and most dismissed aspects of menopause. Per SWAN data, approximately 60% of women in the menopausal transition report subjective cognitive complaints (memory lapses, slowed thinking, word-finding difficulty). Estrogen supports synaptic function and helps regulate neuroinflammation.

Mood swings, anxiety, and low mood are often misattributed to stress rather than recognized as hormonally driven. Estrogen regulates serotonin and dopamine. A 2015 Nature Reviews Endocrinology review characterized perimenopause as a neurological transition state, legitimizing the cognitive and mood changes women have long described.

Sleep disruption compounds everything. Declining progesterone reduces GABA-mediated calm, and night sweats fragment sleep, worsening mood, cognition, and metabolic health. These are biological shifts, not personal failings, and they respond to clinical treatment.

What Menopause Does to Your Weight, Bones, and Heart

Declining estrogen raises the risk for several longer-term health concerns that extend well beyond menopause itself.

• Weight and metabolism: estrogen decline shifts fat distribution toward the abdomen and influences insulin sensitivity. Longitudinal SWAN data published in JCI Insight in 2019 found midlife women gain on average about 1.5 pounds per year during the transition, much of it as visceral fat.
• Bone density: accelerated bone loss begins in perimenopause. Bone-protective strategies, including appropriate hormone therapy, strength training, and adequate calcium and vitamin D, are essential.
• Cardiovascular health: estrogen supports vascular function and cholesterol balance. After menopause, cardiovascular risk rises sharply as the protective effects of estrogen wane (El Khoudary et al., 2020). Hormone therapy initiated close to menopause onset has been shown to have cardiovascular-protective effects in women under 60 or within 10 years of their final menstrual period.

How is Menopause Diagnosed?

Menopause itself is a clinical determination based on the menstrual history described earlier. FSH (follicle-stimulating hormone) testing can support the diagnosis, but FSH levels fluctuate significantly during perimenopause and a single test is not definitive on its own.

Several other conditions can mimic menopause symptoms, including thyroid dysfunction, which frequently overlaps with this stage of life. At VIMC, the diagnostic workup goes well beyond a basic panel. Providers evaluate estrogen, progesterone, testosterone, DHEA, FSH and estradiol, thyroid function, adrenal markers, and metabolic indicators. The gut-hormone connection is also assessed, since the microbiome plays a meaningful role in estrogen metabolism and symptom severity. The full clinical picture, not a single lab value, guides the plan.

Treatment Options: What the Research Actually Says

There is no universal solution for menopause, which is precisely why individualized care matters.

Menopausal Hormone Therapy (MHT)

MHT remains the most studied and most effective treatment for vasomotor symptoms, and it plays a meaningful role in protecting bone density and cardiovascular health when started early. Many providers became fearful of hormone therapy after the Women's Health Initiative (WHI) study in 2002, but that research has been significantly recontextualized. The WHI used older formulations in older women, and its conclusions were broadly misapplied to younger, recently menopausal women.

In November 2025, the FDA initiated removal of class-wide boxed warnings on menopausal hormone therapy related to cardiovascular disease, breast cancer, and probable dementia. The endometrial cancer warning on systemic estrogen-only products remains. Current Menopause Society guidance supports MHT for most healthy women under 60 or within 10 years of their final menstrual period. At VIMC, this timing window is treated as a guide, not a categorical limit.

Bioidentical hormones, structurally identical to those the body produces, can be used as part of systemic MHT or as targeted localized therapy. A 2022 systematic review and meta-analysis published in Menopause, covering 29 randomized controlled trials, supported the short-term safety profile of compounded bioidentical hormone therapy when paired with appropriate patient selection and monitoring. For women whose primary symptoms are vaginal and urinary, low-dose vaginal estrogen delivers targeted relief with very low systemic absorption.

The Role of Testosterone for Women

Postmenopause is often when testosterone’s absence becomes most noticeable, even though the decline has been underway for years. The ovaries and adrenal glands are the main source of female testosterone, and the ovarian contribution drops sharply after menopause. Women often describe the result as flatness: diminished sexual desire, lost workout stamina, and a general feeling that something is missing.

The United States still has no FDA-approved testosterone formulation specifically for women. This is a regulatory gap, not a clinical one. The 2019 Global Consensus Position Statement on Testosterone Therapy for Women, endorsed by The Menopause Society and the Endocrine Society, validates testosterone's role in postmenopausal sexual function and calls for broader access.

VIMC providers incorporate testosterone into postmenopausal hormone plans when symptoms and labs support its use. Treatment runs alongside estrogen and progesterone management, with the same monitoring rhythm of follow-up labs and clinical check-ins. The goal is to restore the whole hormonal landscape, not just one piece of it.

Non-Hormonal Options: An Integrative Approach

Not every woman wants or needs hormone therapy, and not every symptom requires it. Naturopathic and integrative medicine provides a deep bench of supportive strategies that can be used on their own or layered alongside MHT, drawn from botanical medicine, targeted nutrition, and clinical lifestyle interventions.

Botanical medicine has a long history in menopausal care. Black cohosh remains the most-studied herb for hot flashes, with mixed but documented evidence summarized in National Center for Complementary and Integrative Health (NCCIH) resources. Red clover isoflavones act as phytoestrogens and are often used to soften vasomotor symptoms in women who prefer not to take MHT. Ashwagandha works as an adaptogen, helping regulate cortisol, sleep, and mood. Maca root, used traditionally for vitality, is often considered for energy and libido support in postmenopausal women.

Nutritional support reinforces the systems most affected by estrogen decline. Vitamin D and adequate calcium protect bone density as estrogen’s bone-preserving role recedes. Magnesium addresses sleep, muscle cramping, and the stress response. Omega-3 fatty acids support inflammation and cardiovascular health, which become more important after menopause. B-complex vitamins, particularly B6, support neurotransmitter production tied to mood and cognition. Many midlife women carry one or more of these deficiencies without realizing it.

Conventional medicine offers pharmaceutical non-hormonal routes that can be appropriate in specific cases. Low-dose SSRIs or SNRIs may be used to dampen hot flashes and stabilize mood. Gabapentin is sometimes prescribed for vasomotor symptoms and sleep. These are tools that may be considered when indicated, though they are not the practice’s starting point. Because supplement potency, purity, and drug interactions vary significantly across products, any botanical or nutritional protocol should be designed and monitored with provider guidance.

Lifestyle Strategies That Make a Measurable Difference

Anti-inflammatory nutrition, regular strength training, and consistent aerobic activity have strong evidence supporting their role in reducing symptom burden and protecting long-term bone, heart, and brain health. Aim for at least 150 minutes of moderate-intensity exercise per week with two or more sessions of strength training. Sleep hygiene, stress management, and cognitive behavioral therapy (CBT) all have meaningful clinical evidence in menopause care.

How the VIMC Team Approaches Menopause Care

At Venus Integrative Medical Center, menopause is treated as a meaningful clinical event, not a phase to outlast. The team sees women who have spent years collecting prescriptions without explanation, or who were told that hormone therapy is no longer safe based on outdated information. The approach here is different: clarify what is actually happening hormonally, present every reasonable option, and choose the path that matches the patient’s biology and goals.

That approach takes time. A first visit is an extended conversation about symptoms, history, and goals, followed by lab work designed to capture the full hormonal and metabolic picture. Treatment plans are built piece by piece, often combining hormone therapy with botanical, nutritional, and lifestyle support. Two women in similar circumstances can leave the practice with very different protocols because the underlying biology and goals are different.

Ready to Take the Next Step?

Menopause is not the end of anything. It is a significant transition that deserves real medical attention and real support. With the right care, many women report feeling stronger, clearer, and more like themselves on the other side. Contact Venus Integrative Medical Center to learn how a personalized approach to menopause care can support you.